Keyphrases
Phase I Clinical Trial
100%
Model-based Design
100%
Operating Characteristics
66%
Probability Intervals
66%
Continual Reassessment Method
66%
Keyboard Design
66%
Bayesian Optimal Interval Design
66%
Maximum Tolerated Dose
33%
Phase I Trial
33%
Algorithm Design
33%
Superior Performance
33%
Interval Design
33%
Uniform Algorithm
33%
Statistical Foundation
33%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Phase I Trials
100%
Toxic Injury
100%
Dose Toxicity
100%
Maximum Tolerated Dose
100%
Mathematics
Bayesian
100%
Probability Interval
100%
Reassessment
100%
Trial Design
50%
Engineering
Operating Characteristic
100%
Reassessment
100%
Computer Science
Keyboard Design
100%
Superior Performance
50%